Title: Activity of tigecycline and comparators against recent clinical isolates of Finegoldia magna from Europe.
Authors: Hawser, S. P.
Abstract: A total of 206 clinical isolates of Finegoldia magna were collected during the period 2007–2009 from six European countries. The majority of isolates were from body fluids ( n = 83; 40.3%) or wounds ( n = 82; 39.8%). All isolates were susceptible to tigecycline, meropenem, metronidazole and piperacillin / tazobactam, though susceptibility to penicillin (86.4–87.4%) and clindamycin (78.2–93.3%) were more variable.
Subjects: EUROPE; BODY fluids; ANAEROBIC bacteria; METRONIDAZOLE; PATHOGENIC bacteria
Publication: European Journal of Clinical Microbiology & Infectious Diseases, 2010, Vol 29, Issue 8, p1011
ISSN: 0934-9723
Publication type: Academic Journal
DOI: 10.1007/s10096-010-0962-7

Activity of tigecycline and comparators against recent clinical isolates of Finegoldia magna from Europe.

Hawser, S. P.